# Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes

> **NCT04633551** · NA · COMPLETED · sponsor: **University of South Carolina** · enrollment: 9 (actual)

## Conditions studied

- Pre-Eclampsia
- Pre-Term
- Intrauterine Growth Restriction
- Hypertension in Pregnancy

## Interventions

- **DIETARY_SUPPLEMENT:** Anti-inflammatory supplement

## Key facts

- **NCT ID:** NCT04633551
- **Lead sponsor:** University of South Carolina
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-01
- **Primary completion:** 2021-06-30
- **Final completion:** 2022-05-30
- **Target enrollment:** 9 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04633551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04633551, "Vascular Inflammation and Anti-inflammatory Supplements After Adverse Pregnancy Outcomes". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04633551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*